Heartburn medications use during pregnancy tied to asthma risk in children | Meta-analysis

  • J Allergy Clin Immunol

  • from Deepa Koli
  • Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Use of acid-suppressive medications during pregnancy was associated with 36% increase in risk for asthma in offsprings.
  • This risk was higher with H2-receptor antagonists (H2RA) use vs proton pump inhibitors (PPI).

Why this matters

  • Dyspepsia and gastroesophageal reflux disease are common in pregnant women.
  • Previous studies on the use of acid-suppressive medications during pregnancy and risk for asthma in offsprings have shown inconsistent results.

Study design

  • This meta-analysis included analytical epidemiological studies in women during preconception and pregnancy and their offspring who were aged ≤17 y.
  • Funding: None.

Key results

  • 8 studies with 1,620,043 participants were included.
  • The use of acid-suppressive medications was associated with significant risk for asthma (risk ratio, 1.36; I2, 87.6%).
  • H2RA (HR, 1.46; I2, 15.3%) showed higher risk for asthma vs PPI (HR, 1.30; I2, 45.2%).
  • No conclusion could be made on association of use during any specific trimester and development of asthma.

Limitations

  • Unmeasured confounding factors could have influenced observation.
  • Risk for publication bias.